Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1141839.RACg8Xl0IqI3hBARaogeGqvv9Vt2q9nT2j3ks7yR72y9k130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1141839.RACg8Xl0IqI3hBARaogeGqvv9Vt2q9nT2j3ks7yR72y9k130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1141839.RACg8Xl0IqI3hBARaogeGqvv9Vt2q9nT2j3ks7yR72y9k130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1141839.RACg8Xl0IqI3hBARaogeGqvv9Vt2q9nT2j3ks7yR72y9k130_provenance.
- NP1141839.RACg8Xl0IqI3hBARaogeGqvv9Vt2q9nT2j3ks7yR72y9k130_assertion description "[before RRBSO and with no clinical signs of ovarian cancer) CA125 level was 9.0 U/ml (range 2-78) and was 10.0 U/ml (range 1-43) in 115 BRCA2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1141839.RACg8Xl0IqI3hBARaogeGqvv9Vt2q9nT2j3ks7yR72y9k130_provenance.
- NP1141839.RACg8Xl0IqI3hBARaogeGqvv9Vt2q9nT2j3ks7yR72y9k130_assertion evidence source_evidence_literature NP1141839.RACg8Xl0IqI3hBARaogeGqvv9Vt2q9nT2j3ks7yR72y9k130_provenance.
- NP1141839.RACg8Xl0IqI3hBARaogeGqvv9Vt2q9nT2j3ks7yR72y9k130_assertion SIO_000772 24389956 NP1141839.RACg8Xl0IqI3hBARaogeGqvv9Vt2q9nT2j3ks7yR72y9k130_provenance.
- NP1141839.RACg8Xl0IqI3hBARaogeGqvv9Vt2q9nT2j3ks7yR72y9k130_assertion wasDerivedFrom befree-2016 NP1141839.RACg8Xl0IqI3hBARaogeGqvv9Vt2q9nT2j3ks7yR72y9k130_provenance.
- NP1141839.RACg8Xl0IqI3hBARaogeGqvv9Vt2q9nT2j3ks7yR72y9k130_assertion wasGeneratedBy ECO_0000203 NP1141839.RACg8Xl0IqI3hBARaogeGqvv9Vt2q9nT2j3ks7yR72y9k130_provenance.
- befree-2016 importedOn "2016-02-19" NP1141839.RACg8Xl0IqI3hBARaogeGqvv9Vt2q9nT2j3ks7yR72y9k130_provenance.